| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2894502 | Atherosclerosis | 2008 | 7 Pages |
Abstract
Lipid-modifying therapy with micro-coated fenofibrate in patients with low high-density lipoprotein levels not only reduced atherogenic lipids (total cholesterol, triglycerides, oxidized low-density lipoprotein and apolipoprotein-B) and increased atheroprotective lipids but also increased paraoxonase1 concentration and activity. Increasing paraoxonase1 levels by fenofibrate may play an important role in decreasing low-density lipoprotein oxidation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Wimon Phuntuwate, Chuthamanee Suthisisang, Banhan Koanantakul, Preecha Chaloeiphap, Bharti Mackness, Mike Mackness,